HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Walgreens/Rite Aid Deal; Indie Beauty; More

This article was originally published in The Rose Sheet

Executive Summary

Walgreens Boots Alliance acquires Rite Aid in a $17.2 billion deal. Market researcher Kline & Co. estimates that indie cosmetics brands grew almost 19% in 2014. More news in brief.

You may also be interested in...



Coty Acquires Peer-To-Peer Social-Selling Platform Younique For $600M

Younique takes the more traditional direct-sales model in which independent reps sell beauty products to family, friends and acquaintances via home parties – and perhaps recruit a few attendees for their down lines in the process – and moves it to the social media sphere. Coty is acquiring a 60% stake in the business, with plans for global expansion.

Bragg Live Wants Consumers To Know Efficacy Differs Among Apple Cider Vinegar Formats

Bragg Live says its survey highlights misconceptions consumers have concerning health benefits and efficacy of different delivery formats of apple cider vinegar.

Another Advertising Review For Goli Nutrition: Church & Dwight Challenges Ashwagandha Claims

NAD review of Goli claims, looking at weight loss, physical performance, sexual function and sales claims, recommended it modify advertising to avoid conveying implied product efficacy claims for Ashwagandha Gummies and modify or discontinue qualified physical performance claim about ingredient KSM-66.

Related Companies

UsernamePublicRestriction

Register

RS019708

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel